Jamjoom Pharmaceuticals Factory Company (TADAWUL: 4015)

Jamjoom Pharmaceuticals Factory Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,836	8,050	-	-	-	-
Enterprise Value	10,716	7,954	-	-	-	-
Last Close Price	154.80	112.65	-	-	-	-
PE Ratio	31.01	26.97	-	-	-	-
Forward PE	25.98	25.41	-	-	-	-
PS Ratio	8.55	7.31	-	-	-	-
PB Ratio	7.50	5.73	-	-	-	-
P/TBV Ratio	9.31	5.79	-	-	-	-
P/FCF Ratio	42.56	32.09	-	-	-	-
P/OCF Ratio	43.02	27.19	-	-	-	-
PEG Ratio	1.62	1.01	-	-	-	-
EV/Sales Ratio	8.45	7.23	-	-	-	-
EV/EBITDA Ratio	25.43	23.27	-	-	-	-
EV/EBIT Ratio	27.66	25.18	-	-	-	-
EV/FCF Ratio	42.09	31.71	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.08	0.03
Debt / EBITDA Ratio	0.01	0.01	0.01	0.01	0.34	0.17
Debt / FCF Ratio	0.01	0.01	0.02	0.02	0.86	0.27
Asset Turnover	0.72	0.72	0.65	0.50	0.58	0.59
Inventory Turnover	2.24	2.18	2.44	1.97	2.99	2.91
Quick Ratio	2.43	3.58	4.16	3.90	2.90	4.80
Current Ratio	3.34	5.04	5.42	5.06	3.54	5.65
Return on Equity (ROE)	24.90%	22.32%	14.00%	14.16%	18.40%	15.17%
Return on Assets (ROA)	13.20%	12.90%	10.67%	7.93%	10.79%	8.76%
Return on Capital (ROIC)	16.51%	15.04%	12.36%	9.25%	12.59%	10.14%
Earnings Yield	3.22%	3.63%	-	-	-	-
FCF Yield	2.35%	3.12%	-	-	-	-
Dividend Yield	2.14%	2.22%	-	-	-	-
Payout Ratio	62.11%	23.94%	86.85%	66.40%	43.83%	54.80%
Buyback Yield / Dilution	-	-600.00%	-	-	-
Total Shareholder Return	2.14%	2.22%	-600.00%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.